Tech Company Financing Transactions
Elucidata Funding Round
Eight Roads, F-Prime Capital and Hyperplane Venture Capital participated in a $16 million Series A funding round for Elucidata. The round was announced on 9/27/2022.
Transaction Overview
Company Name
Announced On
9/27/2022
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Eight Roads (Lead Investor)
Hyperplane Venture Capital (Vivjan Myrto)
Proceeds Purpose
The company intends to use the funds to deepen product capabilities in translational drug research and allied markets, scale go-to-market initiatives, and accelerate global expansion of operations.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
625 Massachusetts Ave. 2nd Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Elucidata was founded in 2015 with the mandate to transform the way biological data is used to drive decisions in R&D labs in both academia and industry. Polly, an end-to-end, vendor-neutral, cloud-based platform standardizes and streamlines the data analysis workflows for -omics experiments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Nick Pullen
Chief Executive Officer
Abhishek Jha
Chief Technical Officer
Swetabh Pathak
Co-Founder
Richard Kibbey
VP - Bus. Development
James Martin
VP - Engineering
Sony Kadvan
Browse more venture capital transactions:
Prev: 9/27/2022: Employee Cycle venture capital transaction
Next: 9/27/2022: Carbonfuture venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs